Cite
HARVARD Citation
Numan, Y. et al. (2022). Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors. American journal of hematology. 97 (3), pp. 322-328. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Numan, Y. et al. (2022). Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors. American journal of hematology. 97 (3), pp. 322-328. [Online].